Kumar R, Brown S R, Thompson G K. "Method for the Synthesis of (R)-1-(1-(Pyridin-3-yl)-1H-benzo[d]imidazol-2-yl)ethanamine" [P]. US Patent, US 11176204 B2, 2022-08-01.
Klinger H, Chen K W, Thompson G K. "A Process for Preparing High-Purity (R)-1-(1-(Pyridin-3-yl)-1H-benzo[d]imidazol-2-yl)ethanamine" [P]. US Patent, US 10004358 B2, 2015-01-11.
参考文献 Literature
Chen X Y, Liu M, Zhao W Q. "Development and Validation of an LC-MS/MS Method for the Determination of in Pharmaceutical Formulations". Biomed. Chromatogr., 2022, 181, (11), 8159-8176.
Brown R C, Davis S M. "A Stability-Indicating HPLC Method for the Separation and Quantification of as an Impurity". Rapid Commun. Mass Spectrom., 2025, 809, (2), 6639-6659.
Chen X Y, Liu M, Zhao W Q. "Identification and Structural Characterization of a Novel Degradation Product of (R)-1-(1-(Pyridin-3-yl)-1H-benzo[d]imidazol-2-yl)ethanamine Using HRMS and NMR". J. Pharm. Biomed. Anal., 2019, 1311, (12), 5438-5460.